External Validation of Toulouse-Rangueil eGFR12 Prediction Model After Living Donor Nephrectomy
Transplant International · 2023
DOI: 10.3389/ti.2023.11619 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant International, 2023. Verfasst von Suhani S Patel und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Transplant Institute, NYU Langone Health, New York, NY, United States. Hauptthemen laut MEDLINE: Kidney Transplantation, Kidney Failure, Chronic. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Decreased postdonation eGFR is associated with a higher risk of ESRD after living kidney donation, even when accounting for predonation characteristics. The Toulouse-Rangueil model (TRM) estimates 12 month postdonation eGFR (eGFR12) to inform counseling of candidates for living donation. The TRM was validated in several single-center European cohorts but has not been validated in US donors. We assessed the TRM in living kidney donors in the US using SRTR data 1/2000–6/2021. We compared the 2021 CKD-EPI equation eGFR12 observed estimates to the TRM eGFR12 predictions. Median (IQR) bias was −3.4 (−9.3, 3.4) mL/min/1.73 m 2 . Bias was higher for males vs. females (bias [IQR] −4.4 [−9.9, 1.8] vs. −2.9 [−8.8, 4.1]) and younger (31–40) vs. older donors (>50) (bias −4.9 [−10.6, 3.0] vs. −2.1 [−7.5, 4.0]). Bias was also larger for Black vs. White donors (bias (−6.7 [−12.1, −0.3], p < 0.001) vs. (−3.4 [−9.1, 3.1], p < 0.001)). Overall correlation was 0.71. In a sensitivity analysis using the 2009 CKD-EPI equation, results were generally consistent with exception to a higher overall bias (bias −4.2 [−9.8, 2.4]). The TRM overestimates postdonation renal function among US donors. Overestimation was greatest for those at higher risk for postdonation ESRD including male, Black, and younger donors. A new equation is needed to estimate postdonation renal function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Transplant Institute, NYU Langone Health, New York, NY, United States.
- School of Medicine, University of California, Irvine, Irvine, CA, United States.
- Scientific Registry of Transplant Recipients, Minneapolis, MN, United States.
Förderung
- NIDDK NIH HHS
- NIAID NIH HHS
Zitieren
APA
Patel, S. S., Lonze, B. E., Chiang, T. P., Al Ammary, F., Segev, D. L., & Massie, A. B. (2023). External Validation of Toulouse-Rangueil eGFR12 Prediction Model After Living Donor Nephrectomy. Transplant International. https://doi.org/10.3389/ti.2023.11619
Vancouver
Patel SS, Lonze BE, Chiang TP, Al Ammary F, Segev DL, Massie AB. External Validation of Toulouse-Rangueil eGFR12 Prediction Model After Living Donor Nephrectomy. Transplant International. 2023. doi:10.3389/ti.2023.11619
BibTeX
@article{Patel2023,
author = {Patel, Suhani S and Lonze, Bonnie E and Chiang, Teresa Po-Yu and Al Ammary, Fawaz and Segev, Dorry L and Massie, Allan B},
title = {External Validation of Toulouse-Rangueil eGFR12 Prediction Model After Living Donor Nephrectomy},
journal = {Transplant International},
year = {2023},
doi = {10.3389/ti.2023.11619}
}
EUVIMED